$ICCM +85% Premarket 🚀 🔹 Massive premarket move after IceCure reported a 70% jump in its U.S. active commercial install base for ProSense® 📈 🔹 Growth follow

$ICCM +85% Premarket 🚀 🔹 Massive premarket move after IceCure reported a 70% jump in its U.S. active commercial install base for ProSense® 📈 🔹 Growth follows FDA marketing authorization for breast cancer cryoablation, showing accelerating adoption in the U.S. 🧊 🔹 ProSense® offers a minimally i…